Preterm Feeding Maturity Measurement and Evaluation

Project Information

PREMADES

Grant agreement ID: 651956

DOI

10.3030/651956

Project closed

EC signature date 30 September 2014

Start date 1 October 2014

End date 31 March 2015

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

KUARTISMED MEDIKAL ARASTIRMA GELISTIRME DANISMANLIK EGITIM SANAYI VE TICARET LIMITED SIRKETI
Türkiye

Periodic Reporting for period 1 - PREMADES (Preterm Feeding Maturity Measurement and Evaluation)

Reporting period: 2014-10-01 to 2015-03-31

Summary of the context and overall objectives of the project

Synchronization of sucking, swallowing and breathing is vital for the feeding and hence well-being of newborns. Most of the term infants which born after the regular gestation period have coordinated sucking-swallowing patterns whereas these abilities are underdeveloped in preterm infants. The lack of development of effective feeding in premature infants can cause serious complications such as accidental deposits of food in the respiratory tract and the lungs, respiratory illnesses related problems like brain hypoxia, infections, respiratory arrest and even death. Further, this can also cause preterm infants get tired very quickly during feeding and thus impact their growth negatively. Our product detects and analyzes the feeding maturity of preterm infants in an objective manner, by analyzing the patterns captured from non-invasive sensors. During this action, a thorough analysis of our product and our business is completed. Furthermore, a detailed commercialization plan is set forth including also the operating plan. Finally, risk associated with different aspects of the business plan are assessed and contingency actions are determined.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

A feasibility report including a business plan is prepared which elaborates the future commercialization efforts for our product.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

Under the guidance of this feasibility report our company will continue to develop and commercialize our product. As commercialization efforts come to fruition, that is when our product started to be used by practitioners, not only an important problem for preterm infants will be diagnosed but also better clinical decisions will be made. Additionally, global health system will benefit from successful implementation of the business idea.

Logo of the company